~3
2 known investors
Infermedica develops an AI-powered healthcare platform for symptom assessment, triage, and patient intake that integrates into clinical workflows to improve patient access to care. The platform serves healthcare providers and patients globally across 35 countries, supporting primary care and clinical decision-making across 26 languages.
Founders & leadership
PO
Piotr OrzechowskiCEO
Investors · 2
In the news
- Infermedica raises €26.5 million to expand AI-driven medical guidance platform | EU-Startupseu-startups.com · 2022
- Infermedica Raises $30 million Series B Funding from One Peak to Expand AI-driven Medical Guidance Platform | Healthcare IT Todayhealthcareittoday.com · 2022
- Infermedica raises $30M to expand its AI-based medical guidance platform | TechCrunchtechcrunch.com · 2022
- Infermedica - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxntracxn.com · 2021
- Infermedica raises $10.2 millioncoverager.com · 2020
- Infermedica announces $10.2M series A for triage, symptom checking system | MobiHealthNewsmobihealthnews.com · 2020